ITS Group tackles healthcare shifts amidst price pressure

The company eyes elective care and ageing populations while balancing premium offerings.

ITS Group is sharpening its focus on aging-related healthcare and elective procedures to stay ahead in a rapidly evolving market. Speaking at APHM, co-located with The Health Industry Series – ASEAN 2025 in Malaysia, Dennis Tan, Director of Business Development, outlined the company's approach.

“After COVID, a lot of people are much more aware about healthcare,” Tan said. “Elective care is really growing, so surgery that’s not critical—that’s our focus area.”

He acknowledged increasing competition from lower-cost regional brands, particularly from China. “There may be some price challenges coming, but it creates healthy competition,” Tan said. “We carry more European and US products, so we really have to showcase the features and minimize markups to penetrate the market.”

Tan emphasised that the firm’s strength lies in its premium positioning. “There are always two sets of customers—some are price conscious, and some believe in long-term ROI,” he explained. “Our products belong to higher quality, higher price, but offer longer return on investment.”